Lung Cancer Clinical Trial
Official title:
Psychosocial Consequences of Receiving Results of Lung Cancer Workup by Telephone or In-person
Disclosure of bad news is challenging for patients, relatives and healthcare providers.
Current protocols for breaking bad news assume a single, in-person meeting for breaking bad
news, however cancer workup is not a single event but a consecutive process with several
contacts between patient and physician. Furthermore, an increasing number of patients receive
their cancer diagnosis by telephone.
The investigators want to examine whether having the result of lung cancer workup by
telephone results in worse psychosocial consequences than having the result in-person. Both
groups receive information on possibility of cancer at every patient-physician contact.
Lung cancer is the most common cause of cancer death worldwide. Patient-friendly delivery of
results of lung cancer workup is mandatory in an era of personalized medicine. The
possibility of delivering health care using telephone has been acknowledged for various
medical interactions such as genetic counselling, delivery of screening results, smoking
cessation programmes, palliative interventions, and disclosing result of breast cancer
workup. However, Retrospective observational studies have identified higher patients'
satisfaction scores when the cancer diagnosis is conveyed by a physician with high
communicative skills, in personal rather than in impersonal settings, in-person rather than
by telephone, when the patients had a perception of opportunity to ask questions, and when
conversations lasted more than10 minutes and included discussion of treatment options.
All current models for breaking bad news (SPIKES, Kayes' 10 step-model, PACIENTE, BREAK) all
focus on a single patient-physician encounter, which is in contrast to the organization of
contemporary cancer workup as a flow of examinations and thus multiple encounters.
The study aims to examine the effects on psychosocial consequences of receiving the final
diagnosis of workup of suspected cancer in lung, pleura or mediastinum by telephone versus
in-person when patients receive information on possible malignancy at every patient-physician
encounter.
HYPOTHESES:
The main hypothesis of this study is that having the final diagnosis of cancer workup
delivered by telephone (intervention group) is associated with worse psychosocial
consequences than when delivered in-person (control group). More specifically, the hypothesis
is:
1) Receiving the result of cancer workup results in decreased scores of the disease-specific
questionnaire Consequences of Screening: Lung Cancer (COS-LC) compared to patients receiving
their results in-person.
Potential moderators and mediators:
During the study potential mediating and moderating factors will be explored, e.g. including
socio-demography, comorbidity, and disease-specific factors, will be investigated. Most
importantly, results on patients with confirmed cancer are explored separately as will data
on patients without a final diagnosis of malignancy.
METHODS:
Study design:
The study is a non-pharmacological two-armed randomized controlled trial with intervention
group receiving the result of cancer workup by telephone (telephone group) and active control
group receiving result of cancer workup in-person ("gold standard"; in-person group). Both
groups will otherwise receive the same information and in the same way, thus regardless of
group, all patients are informed on the possibility of malignancy at every patient-physician
encounter.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03918538 -
A Series of Study in Testing Efficacy of Pulmonary Rehabilitation Interventions in Lung Cancer Survivors
|
N/A | |
Recruiting |
NCT05078918 -
Comprehensive Care Program for Their Return to Normal Life Among Lung Cancer Survivors
|
N/A | |
Active, not recruiting |
NCT04548830 -
Safety of Lung Cryobiopsy in People With Cancer
|
Phase 2 | |
Completed |
NCT04633850 -
Implementation of Adjuvants in Intercostal Nerve Blockades for Thoracoscopic Surgery in Pulmonary Cancer Patients
|
||
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT05583916 -
Same Day Discharge for Video-Assisted Thoracoscopic Surgery (VATS) Lung Surgery
|
N/A | |
Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
Not yet recruiting |
NCT06376253 -
A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers
|
Phase 1 | |
Recruiting |
NCT05898594 -
Lung Cancer Screening in High-risk Black Women
|
N/A | |
Active, not recruiting |
NCT05060432 -
Study of EOS-448 With Standard of Care and/or Investigational Therapies in Participants With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT03667716 -
COM701 (an Inhibitor of PVRIG) in Subjects With Advanced Solid Tumors.
|
Phase 1 | |
Active, not recruiting |
NCT03575793 -
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer
|
Phase 1/Phase 2 | |
Terminated |
NCT01624090 -
Mithramycin for Lung, Esophagus, and Other Chest Cancers
|
Phase 2 | |
Terminated |
NCT03275688 -
NanoSpectrometer Biomarker Discovery and Confirmation Study
|
||
Not yet recruiting |
NCT04931420 -
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
|
Phase 2 | |
Recruiting |
NCT06010862 -
Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced/Metastatic Malignant Solid Tumors
|
Phase 1 | |
Recruiting |
NCT06052449 -
Assessing Social Determinants of Health to Increase Cancer Screening
|
N/A | |
Not yet recruiting |
NCT06017271 -
Predictive Value of Epicardial Adipose Tissue for Pulmonary Embolism and Death in Patients With Lung Cancer
|
||
Recruiting |
NCT05787522 -
Efficacy and Safety of AI-assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
|